1. Research Progress of Epigenetic Therapy in Acute Myeloid Leukemia
   香会 杨, 2022, ACM CrossRef
2. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.
   Han-Yu Cao et al, 2022, Hematol Oncol CrossRef
3. Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
   Zanwen Zuo et al, 2022, Genes & Diseases CrossRef
4. Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study
   Zhibo Guo et al, 2023, Hematology CrossRef
5. Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells
   Pooja Yadav et al, 2023, Gene CrossRef
6. DNA Methylation Alterations in Acute Myeloid Leukemia: Therapeutic Potential
   Aysun Adan, 2023 CrossRef
7. Application of prophylactic or pre-emptive therapy after allogeneic transplantation for high-risk patients with t(8;21) acute myeloid leukemia
   Wenwen Guo et al, 2023, Hematology CrossRef
8. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
   Wenwen Guo et al, 2024, Ann Hematol CrossRef
9. Chidamide Induces Cell Cycle Arrest via NR4A3/P21 Axis Upregulation to Suppress Relapsed and Refractory Acute Myeloid Leukemia
   Feng Xuefeng et al, 2024, Biochemical and Biophysical Research Communications CrossRef